Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00006013. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02027220. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03657420. IPD Sharing: NO. Countries: 1. Publications: 0.
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05954780. IPD Sharing: NO. Countries: 2. Publications: 0.
Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency
ClinicalTrials.gov study NCT04240054. IPD Sharing: NO. Countries: 1. Publications: 0.
Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma
ClinicalTrials.gov study NCT05888636. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
BCMA CAR-T for Dynamic High-risk Multiple Myeloma
ClinicalTrials.gov study NCT06880393. IPD Sharing: NO. Countries: 1. Publications: 0.
Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma
ClinicalTrials.gov study NCT02628704. IPD Sharing: YES. Countries: 1. Publications: 0.
Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
ClinicalTrials.gov study NCT03275103. IPD Sharing: NO. Countries: 4. Publications: 0.
A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06934044. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
ClinicalTrials.gov study NCT07280013. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05908396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory T(11;14) Multiple Myeloma
ClinicalTrials.gov study NCT05853965. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00005792. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT04782687. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan
ClinicalTrials.gov study NCT06163040. IPD Sharing: NO. Countries: 1. Publications: 0.
Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05208086. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Role of BCL-B in Multiple Myeloma
ClinicalTrials.gov study NCT01270009. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Open-label Study of Ultra-High Dose Dexamethasone for Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02402725. IPD Sharing: NO. Countries: 1. Publications: 0.
Ph I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05027594. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.